DSM-Firmenich AG
AEX:DSFIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (13.5), the stock would be worth €-57.97 (190% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -15 | €64.4 |
0%
|
| 3-Year Average | 13.5 | €-57.97 |
-190%
|
| 5-Year Average | 13.5 | €-57.97 |
-190%
|
| Industry Average | 26.9 | €-115.22 |
-279%
|
| Country Average | 21.4 | €-91.93 |
-243%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
€15.5B
|
/ |
Jan 2026
€-1.1B
|
= |
|
|
€15.5B
|
/ |
Dec 2026
€893.8m
|
= |
|
|
€15.5B
|
/ |
Dec 2027
€1B
|
= |
|
|
€15.5B
|
/ |
Dec 2028
€1.1B
|
= |
|
|
€15.5B
|
/ |
Dec 2029
€1.3B
|
= |
|
|
€15.5B
|
/ |
Dec 2030
€1.4B
|
= |
|
|
€15.5B
|
/ |
Dec 2031
€1.7B
|
= |
|
|
€15.5B
|
/ |
Dec 2032
€1.8B
|
= |
|
|
€15.5B
|
/ |
Dec 2033
€1.9B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
16.2B EUR | -15 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
83.6B USD | 32.6 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.7T JPY | 26.1 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
76B USD | 36.6 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
274.4B CNY | 20.8 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 24.3 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 61.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.5B USD | 15.6 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 17.5 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 16.5 |
| Median | 21.4 |
| 70th Percentile | 29.9 |
| Max | 546 |
Other Multiples
DSM-Firmenich AG
Glance View
DSM-Firmenich AG is the culmination of a merger between two titans in their respective fields: DSM, a Dutch multinational known for its prowess in health, nutrition, and sustainable living, and Firmenich, a Swiss firm renowned for its legacy in fragrances and flavors. This strategic union blends DSM's strengths in innovative biotechnology and sustainability with Firmenich's expertise in creating unique sensory experiences. As a combined entity, DSM-Firmenich AG operates on the cutting edge of scientific innovation, catering to a diverse array of industries including food and beverages, personal care, and health products. The synergy of DSM's leadership in sustainable solutions with Firmenich's artistry in scent and flavor not only results in high-quality consumer products but also pushes the envelope in terms of environmental responsibility and human health. The company's business model thrives on innovation and a deep understanding of consumer needs. It leverages its extensive research and development capabilities to produce solutions that enhance the taste, texture, and nutritional value of food, alongside creating signature scents for personal and home care products. By consistently investing in technology and sustainable practices, DSM-Firmenich generates revenue through a broad portfolio of offerings that cater to global clients ranging from multinational corporations to niche brands. Their growth is anchored in delivering products that resonate with consumers' increasing demands for sustainability and authenticity, ensuring that every product not only meets the highest standards of quality but also aligns with the values of a rapidly changing world.